Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome

Velen L. Nelson-Degrave, Jessica K. Wickenheisser, Karen L. Hendricks, Tomoichiro Asano, Midori Fujishiro, Richard Legro, Scot Kimball, Jerome F. Strauss, Janette McAllister

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

We have investigated the involvement of the MAPK signaling pathway in increased androgen biosynthesis and CYP17 gene expression in women with polycystic ovary syndrome (PCOS). A comparison of MAPK kinase (MEK1/2) and ERK1/2 phosphorylation in propagated normal and PCOS theca cells, revealed that MEK1/2 phosphorylation was decreased more than 70%, and ERK1/2 phosphorylation was reduced 50% in PCOS cells as compared with normal cells. Infection with dominant-negative MEK1 increased CYP17 mRMA and dehydroepiandrosterone (DHEA) abundance, whereas constitutively active MEK1 reduced DHEA production and CYP17 mRNA abundance. Similarly, the MEK inhibitor, PD98059, increased CYP17 mRNA accumulation and CYP17 promoter activity to levels observed in PCOS cells. Remarkably, in theca cells maintained in the complete absence of insulin, ERK1/2 phosphorylation was decreased in PCOS theca cells as compared with normal theca cells, and CYP17 mRNA and DHEA synthesis were increased in PCOS theca cells. These studies demonstrate that in PCOS cells reduced levels of activated MEK1/2 and ERK1/2 are correlated with increased androgen production, irrespective of the insulin concentration. These findings implicate alterations in the MAPK pathway in the pathogenesis of excessive ovarian androgen production in PCOS.

Original languageEnglish (US)
Pages (from-to)379-390
Number of pages12
JournalMolecular Endocrinology
Volume19
Issue number2
DOIs
StatePublished - Feb 1 2005

Fingerprint

Theca Cells
Polycystic Ovary Syndrome
Mitogen-Activated Protein Kinase Kinases
Steroid 17-alpha-Hydroxylase
Androgens
Phosphotransferases
Dehydroepiandrosterone
Phosphorylation
Messenger RNA
MAP Kinase Kinase 2
Insulin
Gene Expression

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Endocrinology

Cite this

Nelson-Degrave, Velen L. ; Wickenheisser, Jessica K. ; Hendricks, Karen L. ; Asano, Tomoichiro ; Fujishiro, Midori ; Legro, Richard ; Kimball, Scot ; Strauss, Jerome F. ; McAllister, Janette. / Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. In: Molecular Endocrinology. 2005 ; Vol. 19, No. 2. pp. 379-390.
@article{9d91ca44a2664f9fbdd706ea7befa71b,
title = "Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome",
abstract = "We have investigated the involvement of the MAPK signaling pathway in increased androgen biosynthesis and CYP17 gene expression in women with polycystic ovary syndrome (PCOS). A comparison of MAPK kinase (MEK1/2) and ERK1/2 phosphorylation in propagated normal and PCOS theca cells, revealed that MEK1/2 phosphorylation was decreased more than 70{\%}, and ERK1/2 phosphorylation was reduced 50{\%} in PCOS cells as compared with normal cells. Infection with dominant-negative MEK1 increased CYP17 mRMA and dehydroepiandrosterone (DHEA) abundance, whereas constitutively active MEK1 reduced DHEA production and CYP17 mRNA abundance. Similarly, the MEK inhibitor, PD98059, increased CYP17 mRNA accumulation and CYP17 promoter activity to levels observed in PCOS cells. Remarkably, in theca cells maintained in the complete absence of insulin, ERK1/2 phosphorylation was decreased in PCOS theca cells as compared with normal theca cells, and CYP17 mRNA and DHEA synthesis were increased in PCOS theca cells. These studies demonstrate that in PCOS cells reduced levels of activated MEK1/2 and ERK1/2 are correlated with increased androgen production, irrespective of the insulin concentration. These findings implicate alterations in the MAPK pathway in the pathogenesis of excessive ovarian androgen production in PCOS.",
author = "Nelson-Degrave, {Velen L.} and Wickenheisser, {Jessica K.} and Hendricks, {Karen L.} and Tomoichiro Asano and Midori Fujishiro and Richard Legro and Scot Kimball and Strauss, {Jerome F.} and Janette McAllister",
year = "2005",
month = "2",
day = "1",
doi = "10.1210/me.2004-0178",
language = "English (US)",
volume = "19",
pages = "379--390",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "2",

}

Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. / Nelson-Degrave, Velen L.; Wickenheisser, Jessica K.; Hendricks, Karen L.; Asano, Tomoichiro; Fujishiro, Midori; Legro, Richard; Kimball, Scot; Strauss, Jerome F.; McAllister, Janette.

In: Molecular Endocrinology, Vol. 19, No. 2, 01.02.2005, p. 379-390.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome

AU - Nelson-Degrave, Velen L.

AU - Wickenheisser, Jessica K.

AU - Hendricks, Karen L.

AU - Asano, Tomoichiro

AU - Fujishiro, Midori

AU - Legro, Richard

AU - Kimball, Scot

AU - Strauss, Jerome F.

AU - McAllister, Janette

PY - 2005/2/1

Y1 - 2005/2/1

N2 - We have investigated the involvement of the MAPK signaling pathway in increased androgen biosynthesis and CYP17 gene expression in women with polycystic ovary syndrome (PCOS). A comparison of MAPK kinase (MEK1/2) and ERK1/2 phosphorylation in propagated normal and PCOS theca cells, revealed that MEK1/2 phosphorylation was decreased more than 70%, and ERK1/2 phosphorylation was reduced 50% in PCOS cells as compared with normal cells. Infection with dominant-negative MEK1 increased CYP17 mRMA and dehydroepiandrosterone (DHEA) abundance, whereas constitutively active MEK1 reduced DHEA production and CYP17 mRNA abundance. Similarly, the MEK inhibitor, PD98059, increased CYP17 mRNA accumulation and CYP17 promoter activity to levels observed in PCOS cells. Remarkably, in theca cells maintained in the complete absence of insulin, ERK1/2 phosphorylation was decreased in PCOS theca cells as compared with normal theca cells, and CYP17 mRNA and DHEA synthesis were increased in PCOS theca cells. These studies demonstrate that in PCOS cells reduced levels of activated MEK1/2 and ERK1/2 are correlated with increased androgen production, irrespective of the insulin concentration. These findings implicate alterations in the MAPK pathway in the pathogenesis of excessive ovarian androgen production in PCOS.

AB - We have investigated the involvement of the MAPK signaling pathway in increased androgen biosynthesis and CYP17 gene expression in women with polycystic ovary syndrome (PCOS). A comparison of MAPK kinase (MEK1/2) and ERK1/2 phosphorylation in propagated normal and PCOS theca cells, revealed that MEK1/2 phosphorylation was decreased more than 70%, and ERK1/2 phosphorylation was reduced 50% in PCOS cells as compared with normal cells. Infection with dominant-negative MEK1 increased CYP17 mRMA and dehydroepiandrosterone (DHEA) abundance, whereas constitutively active MEK1 reduced DHEA production and CYP17 mRNA abundance. Similarly, the MEK inhibitor, PD98059, increased CYP17 mRNA accumulation and CYP17 promoter activity to levels observed in PCOS cells. Remarkably, in theca cells maintained in the complete absence of insulin, ERK1/2 phosphorylation was decreased in PCOS theca cells as compared with normal theca cells, and CYP17 mRNA and DHEA synthesis were increased in PCOS theca cells. These studies demonstrate that in PCOS cells reduced levels of activated MEK1/2 and ERK1/2 are correlated with increased androgen production, irrespective of the insulin concentration. These findings implicate alterations in the MAPK pathway in the pathogenesis of excessive ovarian androgen production in PCOS.

UR - http://www.scopus.com/inward/record.url?scp=13544276291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13544276291&partnerID=8YFLogxK

U2 - 10.1210/me.2004-0178

DO - 10.1210/me.2004-0178

M3 - Article

VL - 19

SP - 379

EP - 390

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 2

ER -